Glycoprotein IIb/IIIa inhibitors: current indications and future prospects

Am J Med. 2000 Aug 15;109(3):252-4. doi: 10.1016/s0002-9343(00)00527-1.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Abciximab
  • Acute Disease
  • Angioplasty, Balloon, Coronary / methods
  • Angioplasty, Balloon, Coronary / mortality
  • Antibodies, Monoclonal / therapeutic use
  • Anticoagulants / therapeutic use*
  • Clinical Trials as Topic
  • Coronary Disease / drug therapy*
  • Coronary Disease / mortality
  • Coronary Disease / therapy
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
  • Stents
  • Stroke / drug therapy*
  • Syndrome

Substances

  • Antibodies, Monoclonal
  • Anticoagulants
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Abciximab